Biomedical Engineering Reference
In-Depth Information
112. Noterdaeme O., Leslie T. A., Kennedy J. E., Phillips R. R.,
and Brady M. The use of time to maximum enhancement
to indicate areas of ablation following the treatment of liver
tumours with high-intensity focused ultrasound.
Br J Radiol
2009; 82:412-420.
113. Orsi F., Zhang L., Arnone P., Orgera G., Bonomo G., Vigna
P. D., Monfardini L., Zhou K., Chen W., Wang Z., and
Veronesi U. High-intensity focused ultrasound ablation:
Effective and safe therapy for solid tumors in difficult loca-
tions.
Am J Roentgenol
2010; 195:W245-252.
114. Numata K., Fukuda H., Ohto M., Itou R., Nozaki A.,
Kondou M., Morimoto M., Karasawa E., and Tanaka K.
Evaluation of the therapeutic efficacy of high-intensity
focused ultrasound ablation of hepatocellular carcinoma by
three-dimensional sonography with a perflubutane-based
contrastagent.
Eur J Radiol
2010; 75:e67-75.
115. Park M. Y., Jung S. E., Cho S. H., Piao X. H., Hahn S. T.,
Han J. Y., and Woo I. S. Preliminary experience using high
intensity focused ultrasound for treating liver metastasis
from colon and stomach cancer.
Int J Hyperthermia
2009;
25:180-188.
116. Ng K. K., Poon R. T., Chan S. C., Chok K. S., Cheung T.
T., Tung H., Chu F., Tso W. K., Yu W. C., Lo C. M., and
Fan S. T. High-intensity focused ultrasound for hepatocel-
lular carcinoma: A single-center experience.
Ann Surg
2011;
253:981-257.
117. Wu F., Wang Z. B., Cao Y. D., Chen W. Z., Bai J., Zou J.
Z., and Zhu H. A randomised clinical trial of high-inten-
sity focused ultrasound ablation for the treatment of
patients with localised breast cancer.
Br J Cancer
2003; 89:
2227-2233.
118. Wu F., Wang Z. B., Cao Y. D., Zhu X. Q., Zhu H., Chen W. Z.,
and Zou J. Z. “Wide local ablation” of localized breast can-
cer using high intensity focused ultrasound.
J Surg Oncol
2007; 96:130-136.
119. Wu F., Wang Z. B., Cao Y. D., Xu Z. L., Zhou Q., Zhu H., and
Chen W. Z. Heat fixation of cancer cells ablated with high-
intensity-focused ultrasound in patients with breast cancer.
Am J Surg
2006; 192(2): 179-184.
120. Wu F., Wang Z. B., Chen W. Z., Zhu H., Bai J., Zou J. Z., Li
K. Q., Jin C. B., Xie F. L., Su H. B., and Gao G. W. Changes in
biologic characteristics of breast cancer treated with high-
intensity focused ultrasound.
Ultrasound Med Biol
2003; 29:
1487-1492.
121. Wu F., Wang Z. B., Chen W. Z., Zhu H., Bai J., Zou J. Z., Li
K. Q., Jin C. B., Xie F. L., and Su H. B. Extracorporeal high
intensity focused ultrasound treatment for patients with
breast cancer.
Breast Cancer Res Treat
2005; 92: 51-60.
122. Becker G., Winkler J., Hofmann E., and Bogdahn U.
Differentiation between ischemic and hemorrhagic
stroke by transcranial color-coded real-time sonography.
J Neuroimaging
1993; 3:41-47.
123. Bogdahn U., Becker G., Winkler J., Greiner K., Perez J., and
Meurers B. Transcranial color-coded real-time sonography
in adults.
Stroke
1990; 21:1680-1688.
124. Kimura K., Hashimoto Y., Hirano T., Uchino M., and
Ando M. Diagnosis of middle cerebral artery occlusion
with transcranial color-coded real-time sonography.
Am J
Neuroradiol
1996; 17:895-899.
125. Kushner M. J., Zanette E. M., Bastianello S., Mancini G.,
Sacchetti M. L., Carolei A., and Bozzao L. Transcranial
Doppler in acute hemispheric brain infarction.
Neurology
1991; 41:109-113.
126. Martin P. J., Pye I. F., Abbott R. J., and Naylor A. R. Color-
coded ultrasound diagnosis of vascular occlusion in acute
ischemic stroke.
J Neuroimag
1995; 5:152-156.
127. Smith S. W., Trahey G. E., and von Ramm O. T. Phased
array ultrasound imaging through planar tissue layers.
Ultrasound Med Biol
1986; 12:229-243.
128. Fry F. J. Transkull transmission of an intense focused ultra-
sonic beam.
Ultrasound Med Biol
1977; 3:179-184.
129. Fry F. J., and Barger J. E. Acoustical properties of the human
skull.
J Acoust Soc Am
1978; 63:1576-1590.
130. Weis L., in
Surgery for bone and soft-tissue tumors,
eds. M. A.
Simon and D. Springfield, Lippincott-Raven, Philadelphia,
1998.
131. Li C., Zhang W., Fan W., Huang J., Zhang F., and
Wu P. Noninvasive treatment of malignant bone tumors
using high-intensity focused ultrasound.
Cancer
2010;
116:3934-3942.
132. Chen W., and Zhou K. High-intensity focused ultrasound
ablation: A new strategy to manage primary bone tumors.
Curr Opin Orthop
2006; 16: 494-500.
133. Chen W., Zhu H., Zhang L., Li K., Su H., Jin C., Zhou K., Bai
J., Wu F., and Wang Z. Primary bone malignancy: Effective
treatment with high intensity focused ultrasound ablation.
Radiology
2010; 255: 968-978.
134. Reddan D. N., Raj G. V., and Polascik T. J. Management
of small renal tumors: An overview.
Am J Med
2001;
110:558-562.
135. Kohrmann K. U., Michel M. S., Gaa J., Marlinghaus E.,
and Alken P. High intensity focused ultrasound as non-
invasive therapy for multilocal renal cell carcinoma:
Case study and review of the literature.
J Urol
2002;
167:2397-2403.
136. Susani M., Madersbacher S., Kratzik C., Vingers L., and
Marberger M. Morphology of tissue destruction induced by
focused ultrasound.
Eur Urol
1993; 23(Suppl 1):34-38.
137. Marberger M., Schatzl G., Cranston D., and Kennedy J.
E. Extracorporeal ablation of renal tumours with high-
intensity focused ultrasound.
BJU Int
2005; 95(Suppl
2):52-55.
138. Hacker A., Michel M. S., Marlinghaus E., Kohrmann K. U.,
and Alken P. Extracorporeally induced ablation of renal tis-
sue by high-intensity focused ultrasound.
BJU Int
2006; 97:
779-785.
139. Wu F., Wang Z. B., Chen W. Z., Bai J., Zhu H., and Qiao
T. Y. Preliminary experience using high intensity focused
ultrasound for the treatment of patients with advanced
stage renal malignancy.
J Urol
2003; 170:2237-2240.
